Improving testing for hepatitis B before treatment with rituximab

AIMS/OBJECTIVES/BACKGROUND: Individuals with current or previous infection with the hepatitis B virus (HBV) can experience viral reactivation when treated with immunosuppression. Rituximab, an anti-CD20 antibody used to treat many diseases, has potent immunosuppressant effects with a high risk of ca...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Gastroenterol Hepatol
Main Authors: Dyson, Jessica K., Jopson, Laura, Ng, Sarah, Lowery, Matthew, Harwood, Jayne, Waugh, Sheila, Valappil, Manoj, McPherson, Stuart
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams And Wilkins 2016
Teme:
Original Articles: Hepatitis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010281/
https://ncbi.nlm.nih.gov/pubmed/27388147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000000689
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki